Top Abstract Purchase Related
Home
>
Node
>
Subnode

Responsibilities and importance of tumor centers for interdisciplinary tumor therapy

Schlag, P.

Langenbecks Archiv für Chirurgie. Suppl Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 47-53

1990

ISSN/ISBN: 0173-0541
PMID: 1983593
Document Number: 350039
Early diagnosis, therapy and follow-up of tumor patients rest on the three pillars of medical care: tumor centers, hospitals and physicians. The tumor centers are the pace makers and coordinators in the following functions: definition of primary treatment and additional therapies and their standard of quality; implementation of primary multimodal therapies and treatment of rare tumors; development of improved treatment methods for tumor metastases and local recurrence, including surgical treatment; improvement of diagnostic and therapeutic (surgical) potential through interdisciplinary research, especially in the fields of tumor biology and tumor immunology; and establishment of a standardized follow-up and new care and treatment strategies for the improvement of the patients' quality of life.

Document emailed within 1 workday
Secure & encrypted payments

Guggenmoos-Holzmann, I. 1990: Responsibilities of biostatistics for evaluation of treatment results in tumor therapy Langenbecks Archiv für Chirurgie. Suppl Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 65-68
Dvorak, H.F. 1990: Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy Progress in Clinical and Biological Research 354a: 317-330
Cser, I.; Glauber, A. 1973: The importance of plastic resections in tumor therapy Magyar Traumatologia Orthopaedia Es Helyreallito Sebeszet 16(4): 264-273
Von Kleist, S. 1980: Tumor-associated antigens and their importance in tumor diagnosis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 503-506
Yoshioka, Y.; Tsutsumi, Y.; Nakagawa, S.; Mayumi, T. 2004: Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach Current Vascular Pharmacology 2(3): 259-270
Tanigawa, N.; Mizuno, Y.; Hashimura, T.; Honda, K.; Satomura, K.; Hikasa, Y.; Niwa, O.; Sugahara, T.; Yoshida, O.; Kern, D.H. 1984: Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay Cancer Research 44(6): 2309-2312
Suzuki, M. 1986: A basic study on plasma exchange therapy of malignant tumor in tumor bearing rats Nihon Geka Gakkai Zasshi 87(1): 10-19
Winkelhake, J.L.; Stampfl, S.; Zimmerman, R.J. 1987: Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models Cancer Research 47(15): 3948-3953
Iinuma, S.; Schomacker, K.T.; Wagnieres, G.; Rajadhyaksha, M.; Bamberg, M.; Momma, T.; Hasan, T. 1999: In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model Cancer Research 59(24): 6164-6170
Berger, G.; Reszka, R.; Pohlen, U.; Jung, M.; Lucas, S.; Buhr, H.J. 1998: Liposome encapsulation of cystostatic drugs and starch microspheres improve tumor targeting in locoregional therapy. An animal experiment study of CC 531 liver tumor Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 693-697
Zámecník, M.; Sedlácek, P.; Gogora, M.; Mukensnábl, P. 1999: A testicular tumor with features of a sex cord tumor with annular tubules and calcified large-cell Sertoli tumor Ceskoslovenska Patologie 35(1): 20-23
Milas, L.; Ito, H.; Hunter, N.; Jones, S.; Peters, L.J. 1986: Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type Cancer Research 46(2): 723-727
Zieglschmid, V.; Hollmann, C.; Mannel, J.; Albert, W.; Jaeschke-Melli, S.; Eckstein, B.; Hillemann, T.; Greten, T.F.; Gross, E.; Böcher, O. 2007: Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer Anticancer Research 27(4a): 1823-1832
Hoshino, T.; Jiang, Y.Z.; Dunn, D.; Paul, D.; Qazilbash, M.; Cowan, K.; Wang, J.; Barrett, J.; Liu, J. 1998: Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination Cancer Gene Therapy 5(3): 150-157
Warren, P.; Song, W.; Holle, E.; Holmes, L.; Wei, Y.; Li, J.; Wagner, T.; Yu, X. 2002: Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice Anticancer Research 22(2a): 599-604
Raychaudhuri, S.; Saeki, Y.; Chen, J.J.; Iribe, H.; Fuji, H.; Kohler, H. 1987: Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta) Journal of Immunology 139(1): 271-278
Matthaei, H.; Boelke, E.; Eisenberger, C.F.; Alldinger, I.; Krieg, A.; Schmelzle, M.; Poremba, C.; Schellhammer, F.; Knoefel, W.T.; Budach, W.; Peiper, M. 2007: Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgery European Journal of Medical Research 12(12): 591-594
Waynforth, H.B.; Hunter-Craig, C.J. 1981: The Eker renal tumor rat. Tumor transplantability and a re-evaluation of tumor histology Neoplasma 28(3): 309-315
Lubet, R.A.; Carlson, D.E. 1978: Immunity against MOPC 104E plasmacytoma: effects of tumor size and time post therapy on in vivo tumor immunity Journal of the National Cancer Institute 60(5): 1107-1111
Shiio, T.; Ohishi, K.; Tsuchiya, Y.; Niitsu, I.; Hayashibara, H.; Yoshihama, T.; Moriyuki, H. 1988: Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 475-479